Returning to COPHEX 2026 with the Latest Device Innovations 

SHL Medical is a leading exhibition for pharmaceutical, biotech, and cosmetic manufacturing and packaging technology. COPHEX brings together industry experts to explore advancements in drug delivery and manufacturing solutions. 

After the successful launch of Quanta, our automatic, multi-fixed-dose pen injector for cardiometabolic therapies, we will showcase Quanta alongside Reunite, our dual-chamber cartridge-based autoinjector supporting lyophilised drug delivery. 

According to Towards Healthcare, the dual chamber devices market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 8.28 billion in 2026 to approximately USD 13.87 billion by 2035, representing a compound annual growth rate (CAGR) of 5.9% from 2026 to 2035. Growth is driven by the rising demand for self-administrable combination drugs, the need for stable reconstitution and convenient delivery of drugs has led to the development of dual chamber devices. The shift towards patient-centric care and the preference for self-administration and home-care treatment are accelerating the adoption of these devices. 

About SHL Advantec 

SHL Advantec is a specialised sub-group of SHL Medical, established to provide advanced tooling and automation solutions for the healthcare sector and other industries. It aims to enhance production quality and resilience while supporting SHL Medical's growth in the manufacture of self-injection devices. 

It has taken a strategic initiative move of SHL Medical's expansion strategy, integrating existing tooling and automation operations into SHL Advantec to form a global operation network. SHL Advantec will integrate existing tooling and automation operations from SHL Medical, leveraging recent strategic acquisitions to form a global operations network.  

Highly versatile, modular platforms, such as the SMART and AOU, bridge the gap from initial reliability to automated scalability. Already market-proven for the assembly and/or final assembly of products such as SHL Medical’s Molly and Reunite autoinjectors, these solutions are more than just concepts. It also provides fully automated solutions ready to handle that future scale right now. 

The drive to both reliable and innovative advanced manufacturing in this region is palpable, and we are highly optimistic about the manufacturing trajectory in Asia. 

A recent report by Towards Healthcare highlights that the dual chamber devices market is witnessing growth due to the increasing prevalence of biologics and complex drug therapies, which is driving the demand for dual chamber devices to maintain drug stability and dosing accuracy, and a growing preference for patient-centric drug delivery methods and home care settings, which are being supported by dual chamber devices.